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CC BY-NC-ND license (http://creativAbstract Background/Introduction: Urolithiasis is a common disease with high prevalence
and recurrence rates in Taiwan. A national survey in Taiwan determined that 9.6% of the pop-
ulation suffered stones throughout their lifetime.
Purpose/Aim: This study analyzed the epidemiological characteristics and patterns of inpa-
tient treatment for urolithiasis and thus provides a reference for the implementation of future
health strategies.
Methods: A cross-sectional study was conducted using data collected from the Inpatient Ex-
penditures by Admissions and Registry for Contracted Medical Facilities files of the National
Health Insurance Research Database. A total of 40,027 patients were included in the final data
analysis. SPSS 22.0 statistical software was used to analyze the epidemiological characteristics
and corresponding treatments for each patient group.
Results: The average age of the inpatients with urolithiasis was 52  14 years, with a male-to-
female sex ratio of 2.4:1. The highest admission rate occurred between July and August (10.4
e10.6%). Ureteral stones were the most common (76.4%), followed by kidney stones (15.8%),
bladder stones (7.5%), and urethral stones (0.4%). Moreover, 57.4% of the patients were
treated at regional hospitals and 27.5% were treated at medical centers. Of the 4531 urolith-
iasis examinations conducted, 63.6% involved intravenous urography, 21.8% abdominal sonog-
raphy, and 5.9% retrograde pyelography. In total, 13,610 treatments were performed in the
40,027 inpatients with urolithiasis, with a surgical treatment rate of 34%. Extracorporeal shock
wave lithotripsy (ESWL) is the most commonly used treatment for patients with renal or ure-
teral stones with an annual medical expenditure of nearly NT $3 billion. Regional hospitals con-
ducted the highest number of ESWL treatment for inpatients with stones, whereas medical
centers conducted more percutaneous nephrostomy lithotripsy than did regional hospitals.eclare no conflicts of interest.
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Inpatient urolithiasis in Taiwan 137Conclusion: This study reveals patterns in the epidemiology and utilization of medical re-
sources for inpatients with urolithiasis and provides a basis for the implementation of stone
treatment guidelines in Taiwan.
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open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Urolithiasis is a common urologic disease that is increasing
in prevalence in many high-incidence nations.1e3 A national
survey by Lee et al4 in Taiwan determined that 9.6% of the
population suffered stones throughout their lifetime (male
14.5% vs. females 4.3%). Despite the complexity of the
causes of urinary tract stones and the fact that some
mechanisms remain unknown, studies have indicated age,
sex, geography, season, climate, race, obesity, diabetes,
and water intake to be risk factors.5e7 In recent years, the
epidemiology of urolithiasis has changed in line with an
improvement in social conditions, particularly in urban
areas within more affluent developing countries. However,
according to the scholar Bart, “. with the geographical
distribution of urinary tract stones,” people in specific
geographic areas globally are more prone to urinary tract
stones compared with those in other areas.8 In this respect,
Taiwan is located in a geographical belt where urolithiasis is
more likely to occur throughout the lifetime of the popu-
lation, with a prevalence between 4% and 20% at a male-to-
female sex ratio of 2:1. The old Arabian proverb “preven-
tion is better than treatment” is relevant to urolithiasis,
and a patient’s understanding of the disease helps to lower
the prevalence and associated costs. Although statistical
studies on urolithiasis have already been conducted, this
study focused on specific epidemiological groups and their
corresponding treatments.2. Materials and methods
This is a cross-sectional study, and data were obtained from
National Health Insurance Research Database files, namely,
Inpatient Expenditures by Admissions and Registry for
Contracted Medical Facilities, published in 2010; informa-
tion related to ICD-9-CM diagnostic codes 592.X and 594.X
was selected. This study disregarded 192 patients with
incomplete information and 75 patients associated with
coding errors. Therefore, information related to a total of
40,027 patients was used in the final data analysis. The
inpatients were divided into the following groups in
accordance with the site of the stone: kidney stone, ure-
teral stone, bladder stone, and urethral stone. SPSS 22.0
statistical software (SPSS Inc., Chicago, IL, USA) was used
to analyze the epidemiological characteristics and associ-
ated medical treatment among the different groups.
The results are expressed as the mean  standard de-
viation. Statistical analysis was performed using one-way
analysis of variance and a Chi-squared test; a p value < 0.05
was considered significant.3. Results
According to statistics obtained from the Taiwan Ministry of
the Interior, in mid-2010, Taiwan had a population of
23,140,940. Of this number, 40,027 people were admitted
for stone treatment in the year 2010 (at a ratio of 173/
100,000 people). The predominant cause for admission was
ureteral stones (n Z 30,577, 76.4%), followed by kidney
stones (nZ 6307, 15.8%), bladder stones (nZ 2987, 7.5%),
and then urethral stones (n Z 156, 0.4%; Table 1). The
average age of inpatients with urolithiasis was
52.1  14.2 years, with patients with bladder stones having
a higher average age of 66.2  14.1 years. According to the
age chart (Figure 1), the majority of patients with stones
were middle aged, and the number of patients with bladder
stones increased with age. The male-to-female sex ratio
was 2.4:1 for all patients with urolithiasis, 1.6:1 for pa-
tients with renal stones, 2.4:1 for patients with ureteral
stones, 2.1:1 for patients with urethral stones, and 11.1:1
for patients with bladder stones.
For all patients with urolithiasis, the highest admission
rate occurred between July and August (10.4e10.6%; Table
1), but the rate was lower in other seasons (5.3e9.4%;
Figure 2). In addition, the lowest admission rate occurred in
February, which is considered to be related to the Chinese
New Year holiday and patients usually want to postpone
treatment.
The patients’ distribution was as follows: 41.5% in
northern Taiwan (Taipei City, New Taipei City, Keelung City,
Taoyuan, Hsinchu, and Miaoli County), 31.7% in central
Taiwan (Taichung, Changhua, Nantou, Yunlin, and Chiayi
County), 19.9% in southern Taiwan (Tainan, Kaohsiung, and
Pingtung County), and 6.8% in eastern Taiwan (Hualien,
Taitung, and Yilan County; Table 1). The outlying islands
(Penghu, Kinmen, and Matsu County) had the smallest
number of admissions for urolithiasis.
Of the 4531 urolithiasis examinations performed, 2880
(63.6%) were conducted using intravenous urography, 988
with abdominal sonography (21.8%), and 270 with retro-
grade pyelography (5.9%; Table 2). A total of 13,610 (34%)
treatment procedures were performed in the 40,027 pa-
tients, and these procedures included extracorporeal shock
wave lithotripsy (ESWL), percutaneous nephrostomy litho-
tripsy (PCNL), endoscopic manipulation (ureteroscopic
stone fragmentation and removal and cystoscopic electro-
hydraulic lithotripsy), and conventional open methods
(nephrolithotomy, ureterolithotomy, and vesicolithotomy).
Of these, ESWL was the most commonly used treatment for
patients with renal or ureteral stones (Table 2); 53.1%
(2697/5076) of patients with renal stones were treated by
ESWL and 34.9% (1776/5076) by PCNL each year, and 61.4%
Table 1 Epidemiological characteristics of inpatients with urolithiasis in Taiwan (2010).
Location Renal stone Ureteral stone Vesical stone Urethral stone Total p
Case No. (%) 6307 (15.8) 30,577 (76.4) 2987 (7.5) 156 (0.4) 40,027 (100)
Admission prevalence (1/100,000) 27.3 132.1 12.9 0.7 173.0 <0.001
Mean age (y) 53.5  13.7 50.4  13.5 66.2  14.1 50.1  16.6 52.1  14.2
Sex (%) <0.001
Male 3844 (60.9) 21,514 (70.4) 2741 (91.8) 105 (67.3) 28,204 (70.5)
Female 2463 (39.1) 9063 (29.6) 246 (8.2) 51 (32.7) 11,823 (29.5)
Mo (%) <0.001
January 527 (8.4) 2161 (7.1) 181 (6.1) 6 (3.8) 2875 (7.2)
February 317 (5.0) 1643 (5.4) 168 (5.6) 8 (5.1) 2136 (5.3)
March 632 (10.0) 2450 (8.0) 257 (8.6) 13 (8.3) 3352 (8.4)
April 509 (8.1) 2337 (7.6) 235 (7.9) 15 (9.6) 3096 (7.7)
May 599 (9.5) 2781 (9.1) 266 (8.9) 11 (7.1) 3657 (9.1)
June 522 (8.3) 2611 (8.5) 243 (8.1) 16 (10.3) 3392 (8.5)
July 635 (10.1) 3215 (10.5) 304 (10.2) 16 (10.3) 4170 (10.4)
August 537 (8.5) 3384 (11.1) 309 (10.3) 24 (15.4) 4254 (10.6)
September 552 (8.8) 2953 (9.7) 259 (8.7) 13 (8.3) 3777 (9.4)
October 532 (8.4) 2759 (9.0) 277 (9.3) 9 (5.8) 3577 (8.9)
November 486 (7.7) 2153 (7.0) 240 (8.0) 16 (10.3) 2895 (7.2)
December 459 (7.3) 2130 (7.0) 248 (8.3) 9 (5.8) 2846 (7.1)
Area (%) <0.001
Northern 2597 (41.2) 12,740 (41.7) 1190 (39.8) 90 (57.7) 16,617 (41.5)
Middle 1999 (31.7) 9864 (32.3) 783 (26.2) 31 (19.9) 12,677 (31.7)
Southern 1102 (17.5) 6043 (19.8) 778 (26.0) 28 (17.9) 7951 (19.9)
Eastern 606 (9.6) 1888 (6.2) 221 (7.4) 7 (4.5) 2722 (6.8)
Islet 3 (0.0) 42 (0.1) 15 (0.5) 0 (0.0) 60 (0.1)
Medicare unit (%) <0.001
Medical center 2323 (36.8) 7885 (25.8) 777 (26.0) 15 (9.6) 11,000 (27.5)
Regional hospital 3322 (52.7) 17,946 (58.7) 1607 (53.8) 85 (54.5) 22,960 (57.4)
Local hospital 662 (10.5) 4746 (15.5) 603 (20.2) 56 (35.9) 6067 (15.2)
Data are presented as mean  standard deviation (range).
138 D.-S. Yu et al.(4960/8079) of patients with ureteral stones were treated
by ESWL and 30.7% (2481/8079) by endoscopic removal. For
patients with vesical or urethral stones, endoscopy was the
primary treatment.
We determined that 55.5% (7554/13,610) of treatment
procedures were undertaken in regional hospitals, 34.2%
(4653/13,610) in medical centers, and 10.3% (1403/13,610)
in local hospitals (Table 3). Regional hospitals had the
highest ESWL treatment rate overall (4938/7657, 64.5%),
whereas medical centers conducted more PCNL than did -
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Figure 1 Distribution of inpatients with urolithiasis by age
group in Taiwan (2010).regional and local hospitals (53.6% vs. 42.9% and 3.5%).
Regional hospitals also had the highest rate of performing
open surgical methods for stone removal than did medical
centers and local hospitals (51.8% vs. 34.1% and 14.1%).4. Discussion
The lifetime prevalence of kidney stones is approximately
10% in developed countries. The condition most commonly0.00
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Figure 2 Distribution of inpatients with urolithiasis by type
and season in Taiwan (2010).
Table 2 Urolithiasis inpatient examination and surgical treatment methods (Taiwan 2010).
Renal stone Ureteral stone Vesical stone Urethral stone Total
Study
Intravenous urography 343 2434 69 34 2880 (63.6)
Abdominal sonography 175 750 56 7 988 (21.8)
Retrograde pyelography 90 158 14 8 270 (5.9)
Kidneyseuretersebladder radiograph 39 168 39 1 247 (5.5)
Computerized tomography scan 44 83 19 0 146 (3.2)
Total 691 (15.2) 3593 (79.3) 197 (4.3) 50 (1.2) 4531
Surgical treatments
Extracorporeal shock wave lithotripsy 2697 4960 0 0 7657 (56.3)
Percutaneous nephrostomy lithotripsy 1776 200 0 0 1976 (14.5)
Endoscopic manipulation 511 2481 291 12 3295 (24.2)
Open surgery 92 438 151 1 682 (5.0)
Total 5076 (37.3) 8079 (59.4) 442 (3.2) 13 (0.1) 13,610
Data are presented as n or as n (%).
Table 3 Therapeutic procedures performed for inpatients
with urolithiasis in Taiwan at different types of treatment
centers.
Medical
center
Regional
hospital
Local
hospital
Total
Extracorporeal
shock wave
lithotripsy
1768 4938 951 7657 (56.3)
Percutaneous
nephrostomy
lithotripsy
1059 848 69 1976 (14.5)
Endoscopy 1593 1415 287 3295 (24.2)
Open methods 233 353 96 682 (5.0)
Total 4653
(34.2)
7554
(55.5)
1403
(10.3)
13,610
Data are presented as n or as n (%).
Inpatient urolithiasis in Taiwan 139affects people in midadulthood,3,9,10 and incidence rates
have been increasing in many countries in recent
years.11e13 Because Taiwan is a region with high preva-
lence, with a total prevalence of 9600/100,000 people and
an admission prevalence of 173.3/100,000,4 stone treat-
ment has become a major problem for the Health Insurance
Department because of both the high prevalence of uro-
lithiasis and its recurrence rate.
Although most people with urolithiasis are treated
effectively, approximately 40% experience recurrence,
with some experiencing relapse up to five times.14 In
Taiwan, the stone recurrence rate is 6.12% for the 1st year,
but this rate increases to 34.71% within the first 5 years.15
Our data show that patients admitted for stone treatment
had an average age of 52.1 years and that >70% were men.
In addition, peak admission times were in spring and sum-
mer, as confirmed by a previous report,16 and this is pre-
sumably due to the rapid loss of body fluid in a hot climate
when reduced urine output results in a high urine concen-
tration and easy crystal aggregation.17 Eisner et al18reported that high temperatures increase urinary excre-
tion of calcium, resulting in calcium oxalate and calcium
phosphate supersaturation, thereby increasing the risk of
stone formation. More than 70% of the patients studied
lived in midnorthern Taiwan; this number is considered to
be attributed to multiple factors such as the higher popu-
lation density, differing Medicare approaches, and the
availability of Medicare resources within the various re-
gions. The prevalence of pediatric urolithiasis in Taiwan
was 0.047% in 2005, which was much lower than that of
adults19; the peak age of pediatric stone occurrence was
15e18 years and was most commonly associated with uri-
nary tract infection. However, similar to the occurrence
rate of adult urolithiasis, that of pediatric urolithiasis cor-
relates significantly with the urbanization level and
geographic area.
In our study, >76% of the inpatients were admitted for
ureteral stones, either with acute renal colic or obstructive
and complicated urinary tract infection, or other comorbid-
ities. Of the inpatients with stones, 57% were admitted to
regional hospitals, whereas medical centers had the highest
admission rates for inpatients with renal stones compared
with regional hospitals (21% vs. 14%), which may reflect the
higher rate of PCNL treatment due to the larger stone burden
with comorbidities such as infection or obstruction.
Stone occurrence in the urinary bladder or urethra is
relatively rare (<10%) and is mostly caused by prostatic
hyperplasia or a neurogenic bladder in relation to long-term
catheterization in elderly people. Most of these stones
were treated endoscopically using various forms of litho-
tripter, and few patients underwent stone removal via
operative methods.
In 2010, intravenous urography was the most commonly
used method for stone evaluation, followed by computer-
ized tomography scanning as the secondary choice.
Currently, noncontrast computerized tomography scanning
is gradually being implemented as a first-line screening tool
for renal colic patients in the emergency department.
The National Health Insurance Bureau Statistics reveal
that more than NT $2 billion has been spent on ESWL
monotherapy for patients with urolithiasis in Taiwan since
140 D.-S. Yu et al.2004 every year, and that >60,000 patients receive ESWL
treatment each year. In 2011, a total of 64,386 patients
received ESWL treatment for urolithiasis, accounting for a
total number of 87,646 ESWL treatments (average 1.36
times/person) and costing over NT $2.8 billion. However, in
2010, only 7657 ESWL treatments were conducted on in-
patients with urolithiasis, indicating that >90% of ESWL
treatments occurred in outpatient clinics.
High stone recurrence rates combined with expensive
treatment costs place a similarly significant burden on the
health-care system in the United Kingdom, and the man-
agement of stone diseases comprises a significant and
increasing proportion of urological practice, with implica-
tions for workforce planning, training, service delivery, and
research in this field.16,20,21 Turney et al11 reported that the
number of hospitalizations related to upper urinary tract
stone episodes increased from 63% to 83% in the 10-year
period from 2000 to 2010, and that the use of ESWL for
upper tract stones increased from 14,491 cases to 22,402
cases (a 55% increase), with a 69% increase in lithotripsy for
renal stones in the United Kingdom. However, the use of
ESWL is four times higher in Taiwan than in the United
Kingdom in 2010, which may be a result of the differing
treatment guidelines between these two countries.
In the United States in the year 2000, urolithiasis was
the cause of nearly 2 million office visits, 600,000 emer-
gency room visits, and >177,000 hospitalizations, totaling
more than US $2 billion in annual expenditures.22 The cost
appears to be increasing despite a shift from inpatient to
outpatient treatment and the emergence of minimally
invasive treatment methods, and this increase is consid-
ered to be related to an increase in the prevalence of
stone disease. Between 1994 and 2000, the rate of hos-
pitalization for urolithiasis decreased by 15%, the length
of stay decreased from 2.6 days to 2.2 days, and outpa-
tient visits increased by 40%; in addition, between 1992
and 2000, physician office visits increased by 43%.23
However, in 2010 in Taiwan, 40,027 patients were
admitted for urolithiasis treatment out of a total popu-
lation of 23 million, which is proportionately higher than
the rate in the United States11; this difference may be
attributed to either the complexity of the disease or the
difference in health-care systems. By 2010 in Taiwan,
diagnosis-related group items had not yet included inpa-
tient urolithiasis treatment, and therefore, this would
have had no direct effect on the inpatient and outpatient
ratio. Nevertheless, since its inclusion, a certain per-
centage of complex patients may have received inpatient
treatment and this would thus have had a direct influence
on the ratio of inpatients and outpatients. In 2010, the
National Health Insurance coverage rate rose to 99.51%,
and the case study of urolithiasis inpatients presented
here may reflect the state of the Taiwanese health-care
system as a whole. However, limitations still exist as
only 1 year of data have been available from our database
in Taiwan and a serial comparison is lacking.4.1. Conclusion
In conclusion, from our analysis of data published in 2010,
we determined that higher admission rates and usage ofESWL were two primary characteristics of urolithiasis
treatment in Taiwan. This study provides information for
use in medical resource allocation for urolithiasis patient
admissions, and it can be used as a guideline for strate-
gizing and improving stone treatment in the future.References
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